Introduction:
Cardiovascular disease is now recognized as a significant complication of SARS-CoV2 infection. Its pathogenesis is multifactorial and still not completely understood. The combination of accelerated inflammation together with a hypercoagulable state are the most likely triggers.
Methods:
This is a retrospective study of medical records of all COVID-19 patients hospitalized in nephrology at our institution between January and August 2024. Data collected included demographic characteristics, comorbidities, treatments, complications, and outcome.
Results:
We included 8 patients. The mean age was 54 years. 75% of patients received two doses of anti-covid vaccine in 2021, 25% did not. The absence of vaccination was not correlated with the severity of the infection nor with an unfavorable outcome. The most frequent comorbidity was acute renal failure or decompensation of chronic renal failure (75% of cases), followed by hypertension (62%) and diabetes (50%). The mortality rate was 12%, for a single patient suffering from pulmonary embolism. Independent risk factors for mortality were prolonged bed rest and cardivascular comorbidity.
Conclusions:
Chronic kidney disease patients are at high risk for Cardiovascular complications during SARS-CoV-2 infection for multiple reasons. The awareness of chronic implications of COVID-19 on CVD is still limited, especially for the CKD population
I have no potential conflict of interest to disclose.
I did not use generative AI and AI-assisted technologies in the writing process.